7
| Date post: | 30-Mar-2016 |
| Category: |
Documents |
| Upload: | julius-evans |
| View: | 215 times |
| Download: | 1 times |
� Apr - Jun �008
Chem-Bio Defense Quarterly
The Joint Program Executive Office celebrates five years of existence. This issue of the Chem-Bio Defense
Quarterly has articles commemorating the anniversary. Not long ago, the editor received the following letter from Spc. Audrey Davis from 310th Military Police Battalion, Camp Bucca, Iraq.
Mr. Evans, I did receive the magazine while I was there and it was very helpful. My assignment in Iraq was detainee operations, but because I was one of three chemical specialists on the base I was appointed to design the chemical [Standard Operating Procedures] for my [Forward Operating Base]. When I redeployed in July of last year, I was starting to arrange exercises for practice FOB-wide
and I was getting ready to order reconnaissance and decontamination suits and masks for the civilians on the base. Your magazine was very useful when it came time to talk about protection for detainees and equipment I might need down the line in case of FOB-wide evacuation.
I share this letter with you because it exemplifies our mission – getting both the best equipment as well as helpful information to Warfighters, making their job easier, and helping accomplish the mission. What we publish is made possible through your hard work -- both from the members of the Joint Program Executive Office as well as you, the readers, who write in and make valuable suggestions on subjects you wish to learn more about that we aggressively act upon. Feel justifiably proud of your contributions. This issue features interviews with senior leaders in the Chemical, Biological Defense Program, including USAF Maj. Gen. Larry D. New, Deputy Director for Force Protection, Force Structure, Resources and Assessment Directorate, Joint Staff; Mr. Peter Bechtel, Director, Army Nuclear and Combating Weapons of Mass Destruction Agency and Dr. Darrell Galloway, Director, Defense Threat Reduction Agency, Chemical and Biological Technologies Directorate. Also in this issue, Mr. Phil Hunter shares a few personal accounts of American history that give an inside view of who we are as a people and as a nation today. Last month I had the opportunity to testify before the Senate Armed Services Subcommittee on Emerging Threats and Capabilities pertaining to technologies to combat Weapons of Mass Destruction. Testifying with me were Dr. James A. Tegnelia, Director, Defense Threat Reduction Agency and Dr. T. Jan Cerveny, Assistant Deputy Administrator for Nonproliferation Research and Engineering at the Department of Energy’s National Nuclear Safety Administration. The testimony provided the opportunity to share the significant accomplishments of the JPEO over the past five years as well as the challenges ahead. A synopsis of that testimony appears on page 12. This year’s Advance Planning Briefings for Industry will be held at the Washington, DC, Convention Center, Tuesday and Wednesday, May 20-21. These briefs inform the industrial base of future business opportunities, the direction of the Chemical Biological Defense Program (CBDP), and future DoD requirements. They will include details on the Joint Service mid- and long-range science and technology research, development, test, and evaluation plans and programs, as well as future production projections, and emerging military requirements. To all our readers, thank you for what you do – for our national security, for homeland defense and for your interest in the Chemical and Biological Defense Program. Your hard work and dedication make our nation and the world safer every day.
Maj. Gen. Stephen V. Reeves
Joint Program Executive Officer
Mr. Douglas Bryce Deputy Joint Program Executive Officer
Mr. Scott Paris Chief of Staff
Col. Jonathan Newmark Assistant JPEO-CBD for Medical Affairs
Ms. Brenda Besore Director, Knowledge Management
Mr. Charlie Cutshall Director, Resource Management
Ms. Susan Hubbard Director, Management Support
Mr. Gary Olejniczak Director, Current Acquisition
Mr. Rich Floyd Acting Director, Future Acquisition
Mr. Darrell McCarthy Director, Human Resources
Mr. Larry Wakefield Special Assistant for External Affairs
Ms. Patricia Estep Webmaster
Editor, Chem-Bio Defense Magazine
Mr. Julius L. Evans [email protected]
Contractor Support Provided by Kalman & Co., Inc. and Camber Corporation
Mr. Stephen Gude Assistant Editor
Mr. Steven Lusher Senior Graphic Designer
Ms. Tonya Maust Graphic Designer
Ms. Ashlee Burns Graphic Designer
Ms. Jacqueline Grosser Distribution
Chem-Bio Defense Quarterly magazine is published quarterly by the Joint Program Executive
Office for Chemical and Biological Defense. Articles reflect the views of the authors and do
not necessarily represent the views of Chem-Bio Defense Quarterly, the Department of the Army or
the Department of Defense.
To contact the editorial office:
Call: (703) 681-0701 DSN: 588-9600
Fax: (703) 681-3439 Email: [email protected]
Articles should be submitted to:
Chem-Bio Defense Quarterly 5203 Leesburg Pike
Skyline 2, Suite 1609 Falls Church, VA 22041
www.jpeocbd.osd.mil
From the Joint Program Executive Officer Joint Program Executive Office
Maj. Gen. Stephen Reeves Joint Project Executive Officer for Chemical and Biological Defense
18 Apr - Jun �008
Chem-Bio Defense Quarterly
The Joint Program Executive Officer for Chemical and Biologi-cal Defense, Maj. Gen. Stephen
Reeves, testified on technologies to combat Weapons of Mass Destruction (WMD) before the Subcommittee on Emerging Threats and Capabilities of the United States Senate Committee on Armed Services, March 12, 2008. Prior to the testimony, a technology demonstra-tion was held in the hearing room located in the Dirksen Senate Office Building on Capitol Hill. Testifying alongside Maj. Gen. Reeves on the three-witness panel were Dr. James A. Tegnelia, Direc-tor, Defense Threat Reduction Agency (DTRA) and Dr. T. Jan Cerveny, the Assistant Deputy Administrator for Non-proliferation Research and Engineering at the Department of Energy’s National Nuclear Safety Administration (NNSA). The hearing was part of the Senate Armed Services Committee’s consider-ation of the Fiscal Year 2009 Department of Defense (DoD) Budget Request and the Committee’s formulation of the Fiscal Year 2009 National Defense Authoriza-tion Act (NDAA). Along with their House of Representatives counterpart, the House Committee on Armed Services, the Senate Armed Services Committee is responsible for drafting the NDAA, the annual authorizing legislation for all DoD and mili-tary service operations, offices, and programs. The Subcom-mittee on
Emerging Threats and Capabilities has oversight responsibilities for, among other areas, DoD efforts concerning terrorism, homeland defense, chemical and biologi-cal warfare defense, chemical demilitar-ization, and non-proliferation programs, as well as Northern Command, the Defense Advanced Research Projects Agency (DARPA), and DTRA. The emphasis for the technology demonstration was on those systems that constitute and enhance the DoD capabil-ity to manage the WMD threat to both military and civilian populations. The demonstration featured various Joint Pro-gram Executive Office for Chemical and Biological Defense (JPEO-CBD) systems to detect, protect against, and coordinate the response to a WMD event. Maj. Gen. Reeves guided House and Senate staff members and several senators through the JPEO-CBD exhibit, including Sena-tor Elizabeth Dole (R-NC), Senator John Warner (R-VA), and Senator Jack Reed (D-RI). Senator Reed is the chairman of the Subcommittee on Emerging Threats and Capabilities, Senator Dole is the rank-
ing member or senior Republican on the panel, and Senator
Warner represents the state of Virginia
where the head-quarters of the
JPEO-CBD, Joint
Project Manager (JPM) Individual Protec-tion, JPM Collective Protection, JPM Guardian, and JPM Decontamination are located. The Department of Energy, DTRA, and DARP A also participated in the demonstration. Other military services participating included the Air Force and the Navy. Subject matter experts from the JPEO-CBD demonstrated for the senators and congressional staff members the current DoD Individual Protective Equipment, the current Civil Support Team Personal Protective Equipment, the Joint Service Chemical Environment Survivability Mask, the Next-Generation Mask-Helmet Concept, the Installation Protection Program Decision Support System Dem-onstrator, a CBRN Unmanned Ground Reconnaissance Vehicle, the Joint Chemi-cal Agent Detector, the Expeditionary Biological Detector, and other products and systems used by the national defense and consequence management com-munities. Both Senator Reed and Senator Dole were grate-ful to
By James Beauchamp, JPEO-CBD Congressional Liaison/Camber Corporation, photos by Steve Lusher
www.jpeocbd.osd.mil
JPEO-CBD
1�
Maj. Gen. Reeves, Dr. Tegnelia, and Dr. Cerveny for agreeing to testify and to the technology demonstration participants for providing their systems. Regarding the JPEO-CBD, Senator Reed noted at the outset of the hearing that, “[i]t is one of the less well-known success stories that the Department of Defense has a single joint program for all chemical and biologi-cal defense efforts.” During the hearing, the Subcommittee directed questions to the three witnesses which focused on the WMD threat, the DoD response to the WMD threat, and ongoing challenges to capability development. In his remarks, Maj. Gen. Reeves emphasized that the JPEO-CBD works every day to “support the force in current operations,” “improve our current field of capability,” and “build for the future.” He informed the Subcommittee that the JPEO-CBD fielded over 1.2 million indi-vidual items of equipment in Fiscal Year 2007 alone. Maj. Gen. Reeves reported that JPEO-CBD coordination with the Department of Health and Human Ser-vices has
“provided anthrax and smallpox vaccines to both our Warfighters, as well as to the U.S. Strategic National Stockpile.” On the
issue of cooperation with civilian authori-ties, he stated that DoD “has strengthened its partnerships over the last five years with federal, state, and local agencies to ensure U.S. military installations are pre-pared to mutually support and interoperate in the civilian communities in which they reside.” With respect to technology transition
toward capability development, Maj. Gen. Reeves described his approach as the material developer. He explained
the formal process to ensure that DoD sci-ence and technology investments transition to advanced develop-ment and procure-ment. Looking ahead at future threats, Maj. Gen. Reeves stated his goal is to ensure that Warfighters are
“never technologically surprised.” He observed that uncertainty is “the defin-ing characteristic of the present and future environment” and therefore DoD needed to prepare U.S. Forces “for a much broader array of threats, including toxic industrial chemicals and materials.” The Joint Program Executive Officer stressed that “the emerging sciences of genom-ics and proteomics and the tools of
genetic engineering” create the potential “for our
“... it is one of the less well-known success stories that the DoD has a single joint program for all chemical and biological defense efforts.”
Sen. Jack Reed, (D-RI)
�0 Apr - Jun �008
Chem-Bio Defense Quarterly
adversaries to develop new and previously unknown toxins, viruses and bacteria.” At the same time, however, the general noted the JPEO-CBD was working to leverage these emerging disciplines to develop genuine capability for rapid, broad-based identification of threats. Maj. Gen. Reeves also explained challenges the JPEO-CBD faces in developing new equipment. He described the challenges of standoff identification of chemical and biological agents, development of detection, protec-tion, and decontaminant capabilities for all hazards, development of common test and performance standards across agen-cies and operations, and countering toxic industrial chemicals in the urban environ-ment. During his appearance, Dr. Tegnelia of DTRA emphasized the nuclear threat. Regarding ‘loose’ nuclear weapons, he stated the most “challenging research and development task” is developing nuclear detection technology with increased range, i.e., “hundreds of meters and kilo-meters.” He indicated demilitarizing or disarming the weapon is obviously peril-ous since today it can only be done near the device. What is needed is a capability to disarm the device from a safe distance, he said. Lastly, Dr. Tegnelia stressed the importance of nuclear forensics. He stated that in the event of an actual detonation, the U.S. Government needs the ability to attribute the device to those responsible for the attack. He reported the U.S. Gov-ernment is “just now at the point where the research and development is beginning to produce a product for which we can field a first nuclear
forensics capability for the subject of attribution.” In her remarks, Dr. Cerveny of NNSA explained that her office (the Office of Nonproliferation Research and Develop-ment) supports NNSA by developing “the next generation of nuclear nonprolifera-tion sensors and detection capabilities” using “a variety of high-tech institutions and organizations, such as leading univer-sities, small businesses, industry and most importantly, the U.S. National Laborato-ries.” She explained her organization is focused programmatically on detection for both “pre-detonation” and “post-deto-nation” scenarios. She stated that these efforts were “supported by enabling tech-nology development in areas like remote sensing, advanced radiation detection materials, and simulation algorithms and modeling.” Lastly, Dr. Cerveny described NNSA’s cooperation with DoD and other federal entities, noting the collective approach seeks to ensure minimal redun-dancy across U.S. Government agencies and programs. After more than two hours for both the technology demonstration and the hearing itself, Sen. Reed gaveled the day’s events to a close and thanked the witnesses “for excellent tes-timony and a wonderful demonstration.” Chairman Reed
stressed that the witnesses had outlined “significant challenges” and therefore continued cooperation between the Senate Armed Services Committee and the chemical, biological, radiological, and nuclear defense (CBRND) community was required. The testimony and responses of Maj. Gen. Reeves, Dr. Tegnelia, and Dr. Cer-veny were well-received by the Sub-committee. The hearing and technology demonstration provided a forum for DoD agencies and officials leading the CBRND effort to provide candid observations and analysis to the Subcommittee, the media, and the public. As the Senate Armed Services Committee continues its consid-eration of the FY09 DoD Budget Request and its formulation of the FY09 NDAA, the JPEO-CBD stands ready to provide additional information as appropriate concerning the WMD threat, the DoD response to the WMD threat, and ongoing challenges to capability development.
Sen. Jack Reed (D-RI), chairman of the Subcommittee on Emerging Threats and Capabilities and Sen. Elizabeth Dole (R-NC), the ranking member of the Subcommittee, prepare to hear testimony on technologies to combat Weapons of Mass Destruction.
www.jpeocbd.osd.mil
JPEO-CBD
�1
Lt. Col. Gregory Green, technical director, Joint Project Manager Guardian, demonstrates equipment for Sen. John Warner (R-VA).
Sen. John Warner (R-VA) speaks with Maj. Gen. Stephen Reeves regarding a Joint Program Executive Office system during the technology demonstration.
Maj. Gen. Stephen Reeves speaks with Sen. Elizabeth Dole (R-NC), the ranking member of the Subcommittee on Emerging Threats and Capabilities.
Maj. Gen. Stephen V. Reeves, the Joint Program Executive Officer for Chemical and Biological Defense, confers with Maj. Gen. Randal R. Castro, the Deputy Director Defense Threat Reduction Agency and Dr. James A. Tegnelia, DTRA Director.
Sen. Jack Reed (D-RI), chairman of the Subcommittee on Emerging Threats and Capabilities and Sen. Elizabeth Dole (R-NC), the ranking member of the Subcommittee, prepare to hear testimony on technologies to combat Weapons of Mass Destruction.